China’s speed in clinical trials draws drugmakers

Oct 30, 2026

The race to accelerate drug development continues, and China appears poised to have a great advantage in clinical trial speed. The good news is that it raising important questions about how the U.S. can remain competitive while maintaining rigorous patient safety and regulatory standards.

Read the full article in Bloomberg here: safety vs. quality vs. speed

Recent News

Surviving the Squeeze

The 2026 Power List discuss strategies for navigating today’s funding landscape in cell and gene therapy Read the full article here: The Medicine...